Home >
Medicine Info >
Combunex 800 Tablet
Loading interface...

Combunex 800 Tablet

Manufactured byLUPIN LTD
ContainsIsoniazid (300 mg) + Ethambutol (800 mg)
Description
Combunex 800 Tablet is a combination medicine which may be used for the treatment of tuberculosis. It is important to continue treatment with this medicine even if the patient feels better; do not stop the use of this medicine without consulting your doctor.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Combunex 800 Tablet

  • Chills
  • Pain and swelling of joint
  • Loss of vision or blurred vision
  • Fever
  • Burning or tingling sensation of hands and feet
  • Skin rash
  • Abdominal pain
  • Confusion
  • Headache
  • Loss of appetite
  • Nausea and vomiting
  • Dark urine
  • Unusual tiredness or weakness

Uses of Combunex 800 Tablet

What is it prescribed for?

  • Tuberculosis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 2-4 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended while receiving this medicine since it may significantly increase the risk of serious adverse effects. These adverse effects may include unusual bleeding or bruising, joint pain or swelling, fever, chills, skin rash, severe abdominal pain, yellowing of the skin or eyes, etc.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to isoniazid, ethambutol or any other inactive ingredients present in the formulation.

Optic neuritis

This medicine is not recommended for use in patients with a history of vision disorder or optic neuritis due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Liver impairment

This medicine should be used with extreme caution in patients with a known history of liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Vision impairment

This medicine may cause vision problems and can be reversible. Any changes in the vision should be reported to the doctor. Inform the doctor if you have any history of eye disorder.

Drug-resistance

Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that is drug resistant.

Driving or Operating machinery

Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended while receiving this medicine since it may significantly increase the risk of serious adverse effects. These adverse effects may include unusual bleeding or bruising, joint pain or swelling, fever, chills, skin rash, severe abdominal pain, yellowing of the skin or eyes, etc.
Interaction with Medicine

Pimozide

Leflunomide

Halothane

Teriflunomide

Citalopram

Atorvastatin

Disease interactions

Liver Disease

This medicine is not recommended for use in patients with acute liver disease or a known history of liver injury due to the use of this medicine. It should be used with caution in patients with a history of liver diseases due to the increased risk of serious liver injuries which may be fatal. Close monitoring of liver function tests is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Peripheral Neuropathy

This medicine should be used with caution in patients with a known history of peripheral neuropathy due to the increased risk of worsening of the patient's condition. Appropriate corrective measures including vitamin B6 supplementation, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
This medicine should be taken on an empty stomach, at least 1-2 hours before or after a meal since food decreases the absorption of this medicine.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine on an empty stomach, either 1 hour before or 2 hours after a meal. The absorption of this medicine may be reduced if it is taken along with food. Do not consume in larger or smaller amounts than advised. Consult the doctor if the patient experiences any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by inhibiting bacterial cell wall synthesis; this stops the growth of the bacteria and ultimately leads to their death.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antituberculosis combinations

Schedule

Schedule H1

Isoniazid - DrugBank [Internet]. Drugbank.ca. 2018 [cited 15 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB00951

DailyMed - ISONIAZID- isoniazid tablet [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 15 March 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1553312b-ed76-421c-a055-2579bdcf366c

Ethambutol: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 28 April 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a682550.html

[Internet]. 2017 [cited 28 April 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/28702

DailyMed - Ethambutol hydrochloride tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 28 April 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c732b415-e1f9-478f-896d-1dc8b6362da4

[Internet]. Accessdata.fda.gov. 2018 [cited 15 March 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/008678s028lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Jul 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.